Optimal Value-Based Therapy

Ken Schaecher, MD

Video Categories: Polycythemia Vera

Listen as Ken Schaecher, MD discusses the optimal value-based therapy for treatment of polycythemia vera.

Supported through funding from Incyte
October 16, 2015

A Look Into Anti-PD-1 and Anti-PD-L1 Therapies

Dr. Sanjiv Agarwala analyzes anti-PD-1 and anti-PD-L1 therapies in terms what they do and their unique toxicities and response patterns.

July 25, 2018

Best Practices in How Oncologists and Pathologists Can Work Together to Optimize Biomarker Testing for their Patients with Cancer

Dr Sanjiv Agarwala describes best practices developed at St. Luke’s Cancer Center, where a committee has been formed in which clinicians and pathologists meet to reach consensus on reflex testing of molecular biomarkers, as well as the value of biomarker testing in enhancing patient care.